Weighted Average Number of Shares Outstanding, Diluted of Emmaus Life Sciences, Inc. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Emmaus Life Sciences, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • Emmaus Life Sciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 63,865,571, unchanged year-over-year.
  • Emmaus Life Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 63,234,789, a 19% increase from 2023.
  • Emmaus Life Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 53,105,388, a 7.4% increase from 2022.
  • Emmaus Life Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 49,439,867, a 0.38% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Emmaus Life Sciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 63,865,571 0 0% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 63,865,571 +510,450 +0.81% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 63,865,571 +2,019,608 +3.3% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 63,234,789 +10,129,401 +19% 01 Oct 2024 31 Dec 2024 10-K 14 Apr 2025 2024 FY
Q3 2024 63,865,571 -74,509,494 -54% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 63,355,121 +10,489,768 +20% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 61,845,963 +11,136,336 +22% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 53,105,388 +3,665,521 +7.4% 01 Oct 2023 31 Dec 2023 10-K 14 Apr 2025 2024 FY
Q3 2023 138,375,065 +88,816,564 +179% 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024 2024 Q3
Q2 2023 52,865,353 +3,545,358 +7.2% 01 Apr 2023 30 Jun 2023 10-Q 10 Sep 2024 2024 Q2
Q1 2023 50,709,627 +1,397,763 +2.8% 01 Jan 2023 31 Mar 2023 10-Q 10 Sep 2024 2024 Q1
Q4 2022 49,439,867 01 Oct 2022 31 Dec 2022 10-K 03 Jul 2024 2023 FY
Q3 2022 49,558,501 +246,637 +0.5% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 49,319,995 +8,131 +0.02% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 49,311,864 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 49,311,864 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 49,311,864 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2015 101,667,409 +1,900,179 +1.9% 01 Jan 2015 31 Mar 2015 10-Q 18 May 2015 2015 Q2
Q4 2014 101,667,409 -6,180,556 -5.7% 01 Oct 2014 31 Dec 2014 10-Q 13 Feb 2015 2015 Q1
Q1 2014 99,767,230 +77,472,829 +347% 01 Jan 2014 31 Mar 2014 10-Q 18 May 2015 2015 Q2
Q4 2013 107,847,965 +105,823,346 +5227% 01 Oct 2013 31 Dec 2013 10-Q 13 Feb 2015 2015 Q1
Q3 2013 75,800,179 +73,912,671 +3916% 01 Jul 2013 30 Sep 2013 10-K 23 Dec 2013 2013 FY
Q2 2013 42,691,256 +35,590,849 +501% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2013 2013 Q3
Q1 2013 22,294,401 +20,420,453 +1090% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q2
Q4 2012 2,024,619 +151,036 +8.1% 01 Oct 2012 31 Dec 2012 10-Q 13 Feb 2014 2014 Q1
Q3 2012 1,887,508 +18,470 +0.99% 01 Jul 2012 30 Sep 2012 10-K 23 Dec 2013 2013 FY
Q2 2012 7,100,407 +3,150,987 +80% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q3
Q1 2012 1,873,948 +6,484 +0.35% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q2
Q4 2011 1,873,583 -54,150,338 -97% 01 Oct 2011 31 Dec 2011 10-Q/A 22 Feb 2013 2013 Q1
Q3 2011 1,869,038 01 Jul 2011 30 Sep 2011 10-K 15 Jan 2013 2012 FY
Q2 2011 3,949,420 -52,074,501 -93% 01 Apr 2011 30 Jun 2011 10-Q/A 11 Sep 2012 2012 Q3
Q1 2011 1,867,464 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012 2012 Q2
Q4 2010 56,023,921 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012 2012 Q1
Q2 2010 56,023,921 01 Apr 2010 30 Jun 2010 10-Q/A 09 Sep 2011 2011 Q3

Emmaus Life Sciences, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 63,234,789 +10,129,401 +19% 01 Jan 2024 31 Dec 2024 10-K 14 Apr 2025 2024 FY
2023 53,105,388 +3,665,521 +7.4% 01 Jan 2023 31 Dec 2023 10-K 14 Apr 2025 2024 FY
2022 49,439,867 +186,711 +0.38% 01 Jan 2022 31 Dec 2022 10-K 03 Jul 2024 2023 FY
2021 49,253,156 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2013 75,800,179 +73,912,671 +3916% 01 Oct 2012 30 Sep 2013 10-K 23 Dec 2013 2013 FY
2012 1,887,508 +18,470 +0.99% 01 Oct 2011 30 Sep 2012 10-K 23 Dec 2013 2013 FY
2011 1,869,038 -50,408,081 -96% 01 Oct 2010 30 Sep 2011 10-K 15 Jan 2013 2012 FY
2010 52,277,119 01 Oct 2009 30 Sep 2010 10-K 22 Dec 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.